The American drug manufacturer said it would spend up to $500 million to establish a new facility. Officials and activists pointed to more immediate needs.
Tag: Moderna Inc
Pressure Grows on U.S. Companies to Share Covid Vaccine Technology
Moderna accepted $2.5 billion in taxpayer money to develop its Covid-19 vaccine. But officials in the U.S. and overseas are having trouble persuading the company to license its technology.
Moderna vs. Pfizer: Both Knockouts, but One Seems to Have the Edge
A series of studies found that the Moderna vaccine seemed to be more protective as the months passed than the Pfizer-BioNTech vaccine. Here’s why.
Covid Vaccine Prompts Strong Immune Response in Younger Children, Pfizer Says
Vaccinated kids aged 5 to 11 showed evidence of protection against the virus, the company said. The data must be reviewed by the F.D.A. before children can be inoculated.
Health Experts Support Boosters for Americans Aged 60 and Older
Some, however, wondered why the cutoff age is 65, and not 60.
British Officials May Sidestep Watchdog’s No to Covid Vaccines for Young
Health ministers have requested assessments from other medical officials, raising the possibility that the government could take the rare step of defying the vaccine regulator’s advice.
British Officials May Sidestep Watchdog’s No to Covid Vaccines for Young
Health ministers have requested assessments from other medical officials, raising the possibility that the government could take the rare step of defying the vaccine regulator’s advice.
Japan Halts 1.6 Million Doses of the Moderna Vaccine Over Contamination Worries
The problem comes as the country, which initially struggled to get its inoculation program into full gear, confronts its worst wave of Covid-19 cases since the pandemic began.
Biden Falls Short on U.S. Vaccine ‘Arsenal’ Pledge, Experts Say
Congress appropriated $16 billion to ramp up Covid-19 countermeasures, but a new report found that the Biden administration had spent very little of it on expanding vaccine manufacturing capacity.
Vaccine Effectiveness Against Infection May Wane, C.D.C. Studies Find
Federal health officials said the new data justified a campaign of booster shots. But some scientists disagreed, saying not every American needs another dose.